Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study
about
The inflammatory protein Pentraxin 3 in cardiovascular diseaseCardiac biomarkers: new tools for heart failure managementEffect of selenium on markers of risk of pre-eclampsia in UK pregnant women: a randomised, controlled pilot trial.Associations of pentraxin 3 with cardiovascular disease: the Multi-Ethnic Study of AtherosclerosisRole of soluble endothelial cell-selective adhesion molecule biomarker in albuminuria and kidney function changes in patients with coronary artery disease: the Heart and Soul Study.Systemic pentraxin-3 levels reflect vascular enhancement and progression in Takayasu arteritis.Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.Consolidated and emerging inflammatory markers in coronary artery diseasePlasma pentraxin 3 levels do not predict coronary events but reflect metabolic disorders in patients with coronary artery disease in the CARE trial.Analysis of Clinically Relevant Factors for Pulmonary Hypertension in Maintenance Hemodialysis Patients.Association between levels of pentraxin 3 and incidence of chronic kidney disease in the elderly.Emerging families of biomarkers for coronary artery disease: inflammatory mediatorsEvaluation of the association of plasma pentraxin 3 levels with type 2 diabetes and diabetic nephropathy in a Malay populationInteresting Correlation Between the Circulating Pentraxin 3 and Cardiac Rehabilitation Program Outcomes in Coronary Artery Bypass Grafting Patients.Biology of human pentraxin 3 (PTX3) in acute and chronic kidney disease.Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients.Pentraxin-3 Attenuates Renal Damage in Diabetic Nephropathy by Promoting M2 Macrophage Differentiation.Pentraxins in the activation and regulation of innate immunity.Pentraxin 3 as a novel bio-marker of inflammation and endothelial dysfunction in autosomal dominant polycystic kidney disease.Pepsin-pancreatin protein hydrolysates from extruded amaranth inhibit markers of atherosclerosis in LPS-induced THP-1 macrophages-like human cells by reducing expression of proteins in LOX-1 signaling pathway.Correlation between arterial stiffness and inflammatory markers in autosomal dominant polycystic kidney disease patients with preserved renal function.Increased plasma levels of pentraxin 3 in patients with multiple sclerosis and neuromyelitis optica.Pentraxin-3 level at admission is a strong predictor of short-term mortality in a community-based hospital setting.Inflammatory biomarker pentraxin 3 (PTX3) in relation to obesity, body fat depots and weight loss.Relationship Between Plasma Pentraxin 3 Concentration and Platelet Indices in Patients With Stable Coronary Artery Disease.Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases.PTX3, a Humoral Pattern Recognition Molecule, in Innate Immunity, Tissue Repair, and Cancer.C-Reactive Protein Binds to Cholesterol Crystals and Co-Localizes with the Terminal Complement Complex in Human Atherosclerotic Plaques.Long-term prognostic significance of pentraxin-3 in patients with acute myocardial infarction: 5-year prospective cohort study.Relationship between plasma pentraxin 3 level and risk of chronic kidney disease in the Korean elderly: the Dong-gu study.
P2860
Q26738957-9E1B6BA4-73B6-4253-B996-78CC204236DEQ26991726-3B012338-610D-4BC7-BD7C-4EF2A127EFD8Q33744933-A6F29F86-36C0-4629-92DC-396CCBC9D28EQ33748025-83EE065F-1C56-4722-9391-612249243E9FQ33760848-B5513838-3C86-437C-A376-37FE016676B1Q34579101-250010BE-D372-4D8A-9AA9-BAD3B60E3203Q34713240-6A104996-8390-4992-A3F0-C721E0955D1FQ35019922-E4B50C04-D689-4E8F-8B7D-D1E4D14ED437Q35140370-07E35E6C-9C6E-4B1D-907C-650B667C51F1Q36420463-4C7B0DB9-D525-40CE-B355-1ACB8DC3ABB6Q36533057-79FE942D-784E-442A-82D8-BDFB029E3E0DQ37115819-50692898-B64C-4A12-91F8-A3FAF35A353AQ37370584-ACBA3D8B-096C-4A4E-BA94-01A9CF7F2C8AQ37629231-4064012F-506B-42AE-A8BE-B7D3276AF72DQ38084920-72D99231-9754-4A34-8C59-0D648275310AQ38386941-4F2D0AFE-A25B-4CF6-8F88-18113E69ED45Q38901060-788E95F7-DF5D-4BC6-A063-5275C0C392E5Q38991073-407FE218-ED22-4964-A622-B3FE705E05E6Q39252622-006090C3-F1A9-445B-852E-3DCB4DD2C663Q40151204-EBC12154-77BC-49FB-85BA-B081AB1FE92BQ40865321-33737ABC-1B7E-4A1C-9746-FA004DFE8597Q44605195-C6A4C4EB-F1E4-451C-AF36-1B0D7664A2B8Q45110914-0DBB5EC5-EF68-4C35-8A2B-BEA34CA9BE06Q46237239-C1136597-48BD-47AF-B9E0-335CDD617CE5Q48293075-10EA0536-3FD0-43FE-96F7-A2B83756AC34Q49942926-5875C5D2-9B77-44D0-B7E7-0CA36C9D5E11Q50143105-D2570F22-0A41-4D2D-8EAC-8B784FEAB29DQ50277156-C4475524-5F04-4C78-9991-CCF534385994Q51595971-4FEE6361-42CC-4653-8738-5ECE7DC4F3F9Q52761490-2147FC8E-B165-4C23-BF65-BF564F4EFEF9
P2860
Associations of pentraxin-3 with cardiovascular events, incident heart failure, and mortality among persons with coronary heart disease: data from the Heart and Soul Study
description
2012 nî lūn-bûn
@nan
2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@ast
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@en
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@nl
type
label
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@ast
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@en
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@nl
prefLabel
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@ast
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@en
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@nl
P2093
P2860
P50
P1476
Associations of pentraxin-3 wi ...... from the Heart and Soul Study
@en
P2093
Carmen A Peralta
Ruth Dubin
Yongmei Li
P2860
P304
P356
10.1016/J.AHJ.2011.11.007
P407
P577
2012-02-01T00:00:00Z